Nan Fung Life Sciences
North America, California, United States, San Francisco
Description
Nan Fung Life Sciences a global life sciences investment platform with a long-term capital commitment from the Nan Fung Group.
Investor Profile
Nan Fung Life Sciences has made 23 investments, with 0 in the past 12 months and 22% as lead.
Stage Focus
- Series A (30%)
- Series B (26%)
- Series C (22%)
- Series Unknown (9%)
- Series E (4%)
- Seed (4%)
- Series D (4%)
Country Focus
- United States (78%)
- China (13%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Iceland (9%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Biopharma
- Life Science
- Medical Device
- Medical
- Therapeutics
- Wearables
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
